1. Home
  2. INTT vs HUMA Comparison

INTT vs HUMA Comparison

Compare INTT & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo inTest Corporation

INTT

inTest Corporation

HOLD

Current Price

$11.53

Market Cap

139.2M

Sector

Technology

ML Signal

HOLD

Logo Humacyte Inc.

HUMA

Humacyte Inc.

HOLD

Current Price

$0.55

Market Cap

165.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INTT
HUMA
Founded
1981
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
139.2M
165.7M
IPO Year
1997
2020

Fundamental Metrics

Financial Performance
Metric
INTT
HUMA
Price
$11.53
$0.55
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
8
Target Price
★ $13.50
$6.19
AVG Volume (30 Days)
99.1K
★ 4.4M
Earning Date
05-05-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 79.37
EPS
★ 0.06
N/A
Revenue
★ $66,801,000.00
$2,038,000.00
Revenue This Year
$15.82
$444.16
Revenue Next Year
$9.10
$248.39
P/E Ratio
$191.50
★ N/A
Revenue Growth
★ 66.06
N/A
52 Week Low
$7.07
$0.53
52 Week High
$20.00
$2.55

Technical Indicators

Market Signals
Indicator
INTT
HUMA
Relative Strength Index (RSI) 46.94 40.51
Support Level $11.17 $0.54
Resistance Level $11.83 $0.75
Average True Range (ATR) 0.43 0.03
MACD 0.16 0.00
Stochastic Oscillator 67.32 25.39

Price Performance

Historical Comparison
INTT
HUMA

About INTT inTest Corporation

inTest Corp is a supplier of test and process technology solutions for use in manufacturing and testing across a wide range of markets, including Semi, Auto/EV, Defense/Aerospace, Industrial, Life Sciences, Safety/Security, and Other. The Company has three operating segments, which are also its reportable segments and reporting units: Electronic Test, which generates the majority of its revenue and includes semiconductor test equipment, flying probe, and in-circuit testers; Environmental Technologies, which includes thermal test, process, and storage products; and Process Technologies, which includes induction heating and video imaging products. The Company generates the maximum revenue from the U.S.

About HUMA Humacyte Inc.

Humacyte Inc is developing a commercial-stage biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.

Share on Social Networks: